샘플 요청 목록

 카트 문의
시장보고서
상품코드
1986398

북미의 전임상 과학 연구용 의료기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 동물 모델별, 용도별, 고객별, 국가별 및 부문별 예측(2026-2033년)

North America Pre-clinical Scientific Research Medical Device Market Size, Share & Trends Analysis Report By Product, By Animal Model (Rodents, Rabbits, Non-human Primates), By Application, By Customer, By Country, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,861,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 10,350,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 13,329,000
카드담기
※ 부가세 별도
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

북미의 임상 전과 학연구용 의료기기의 요약

북미의 임상 전과 학연구용 의료기기 시장 규모는 2025년에 149억 달러로 추계되며, 2033년까지 233억 8,000만 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 5.92%로 성장할 것으로 전망되고 있습니다.

이 시장의 성장은 주로 의료기기 제조업체의 전임상 연구개발(R&D) 비용 증가, 엄격한 규제 및 안전 요건, 기술 발전, 번역 연구 모델로의 전환에 기인합니다.

북미의 임상 전 과학 연구용 의료기기 산업은 특히 세계 지출을 주도하는 미국의 의료기기 제조업체들의 R&D 투자 증가에 힘입어 빠르게 성장하고 있습니다. 여기에 강력한 벤처 캐피탈, 민간 자금, 그리고 NIH(미국 국립보건원)의 보조금이 혁신을 지원하고 있습니다. 예를 들어 2026년 1월 워싱턴대학교 의과대학(WashU Medicine)은 17억 달러의 스타트업 자금 조달을 보고하여 초기 단계의 연구를 가속화하고 임상 전 장비에 대한 수요를 증가시키고 있습니다. 이러한 투자를 통해 첨단 영상, 모니터링 및 체외 진단 툴이 필요한 진단, 치료 및 의료 기술을 신속하게 개발할 수 있습니다. 또한 NIH의 2024년 예산 470억 달러는 중개연구를 지원하고, 재정적 위험을 완화하며, 전문 전임상 장비 도입을 촉진함으로써 시장 확대를 견인하고 있습니다.

또한 규제 당국, 특히 미국 FDA는 임상시험 및 시판 승인에 앞서 안전성, 기능성, 생체 적합성을 입증하기 위한 포괄적인 전임상 데이터를 요구하고 있으며, 이는 특히 고위험 기기 및 AI 탑재 기기에서 두드러지게 나타나고 있습니다. 이러한 엄격한 기준으로 인해 기업은 신뢰할 수 있고 규제 당국이 승인한 데이터를 생성하기 위해 첨단 이미징 시스템, 모니터링 플랫폼, 투약 장비, 검증된 IVD 툴에 투자해야 합니다. 예를 들어 2025년 4월 FDA는 동물실험과 병행하여 'New Approach Methodologies'를 추진하는 로드맵을 발표하여 데이터의 품질과 재현성에 대한 기대치를 더욱 높였다. 마찬가지로 제조업체들은 첨단 전임상 기술을 채택하고 있으며, 규제 준수가 시장 성장과 혁신의 주요 원동력이 되고 있습니다.

또한 이미징, 분석, 자동화, 데이터 통합 분야의 기술 발전은 전임상 연구의 워크플로우를 변화시키고 첨단 과학 연구 장비에 대한 수요를 주도하고 있습니다. 또한 고해상도 소동물 이미징, 자동 모니터링, 정밀 투약 시스템, 통합 IVD 툴은 정확성, 반복성 및 시간 경과에 따른 데이터 생성을 향상시킵니다. 기기가 점점 더 복잡해짐에 따라 다기능 AI 기반 플랫폼은 더 깊은 생물학적 지식과 더 빠른 규제 당국의 의사결정을 지원할 수 있습니다. 이 외에도 주요 기업은 혁신을 가속화하고 있습니다. 예를 들어 2025년 Revvity는 멀티모달 이미지 분석을 효율화하는 'Living Image Synergy AI' 소프트웨어를 출시했고, Thermo Fisher는 수상 경력에 빛나는 분석 기술을 도입하여 정확도, 처리 능력, 자동화를 향상시켰습니다. 이러한 혁신으로 인해 연구기관과 산업계 전반의 투자와 도입이 확대되고 있습니다.

자주 묻는 질문

  • 북미의 임상 전과 학연구용 의료기기 시장 규모는 어떻게 예측되나요?
  • 북미의 임상 전과 학연구용 의료기기 시장 성장은 어떤 요인에 기인하나요?
  • 미국의 NIH는 북미의 임상 전과 학연구용 의료기기 시장에 어떤 영향을 미치고 있나요?
  • 미국 FDA의 규제는 북미의 임상 전과 학연구용 의료기기 시장에 어떤 영향을 미치나요?
  • 북미의 임상 전과 학연구용 의료기기 시장에서 기술 발전은 어떤 역할을 하고 있나요?
  • 주요 기업들은 북미의 임상 전과 학연구용 의료기기 시장에서 어떤 혁신을 이루고 있나요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 북미의 전임상 과학 연구용 의료기기 시장의 요인, 동향 및 범위

제4장 북미 전임상 과학 연구용 의료기기 시장 : 제품별 추정·동향 분석

제5장 북미의 전임상 과학 연구용 의료기기 시장 : 동물 모델별 추정·동향 분석

제6장 북미 전임상 과학 연구용 의료기기 시장 : 용도별 시장 규모 추정·동향 분석

제7장 북미의 임상 전과 학연구용 의료기기 시장 : 고객별 추정·동향 분석

제8장 북미 전임상 과학 연구용 의료기기 시장 : 국가별 추정·동향 분석

제9장 경쟁 구도

KSA

North America Pre-clinical Scientific Research Medical Device Market Summary

The North America pre-clinical scientific research medical device market size was estimated at USD 14.90 billion in 2025 and is projected to reach USD 23.38 billion by 2033, growing at a CAGR of 5.92% from 2026 to 2033. The market growth is mainly due to rising pre-clinical R&D spending by medical device companies, stringent regulatory and safety requirements and technological advancements and shift toward translational research models.

North America pre-clinical scientific research medical device industry is expanding rapidly, driven by rising R&D investments from medical device manufacturers, particularly in the U.S., which leads the global spending. Besides this, strong venture capital, private funding, and NIH grants support innovation. For instance, in January 2026, WashU Medicine reported USD 1.7 billion in startup funding, accelerating early-stage research and increasing demand for pre-clinical devices. These investments enable rapid development of diagnostics, therapeutics, and medical technologies requiring advanced imaging, monitoring, and in vitro diagnostic tools. In addition, the NIH's USD 47 billion 2024 budget supports translational research, reduces financial risk, and boosts adoption of specialized pre-clinical instrumentation, driving market expansion.

In addition, regulatory authorities, particularly the U.S. FDA, require comprehensive preclinical evidence to demonstrate safety, functionality, and biocompatibility before clinical trials or market approval, especially for high-risk and AI-enabled devices. These stringent standards compel companies to invest in advanced imaging systems, monitoring platforms, dosing equipment, and validated IVD tools to generate reliable, regulator-acceptable data. For instance, in April 2025, FDA introduced a roadmap promoting New Approach Methodologies alongside animal studies, further elevating expectations for data quality and reproducibility. Similarly, manufacturers are adopting sophisticated preclinical technologies, positioning regulatory compliance as a key driver of market growth and innovation.

Furthermore, technological advancements in imaging, analytics, automation, and data integration are transforming pre-clinical research workflows and driving demand for advanced scientific research devices. In addition, high-resolution small-animal imaging, automated monitoring, precision dosing systems, and integrated IVD tools enhance accuracy, reproducibility, and longitudinal data generation. As devices grow more complex, multifunctional and AI-enabled platforms support deeper biological insights and faster regulatory decision-making. Besides this, leading companies are accelerating innovation. For instance, in 2025, Revvity launched Living Image Synergy AI software to streamline multimodal imaging analysis, whereas Thermo Fisher introduced award-winning analytical technologies improving precision, throughput, and automation. These innovations are expanding investment and adoption across research institutions and industry.

North America Pre-clinical Scientific Research Medical Device Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America pre-clinical scientific research medical device market report based on product, animal model, application, customer, and country.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-clinical IVD Systems & Reagents
    • Hematology Analyzers
    • Clinical Chemistry Analyzers
    • Immunoassay Platforms
    • Molecular Diagnostics
    • Others
  • Pre-clinical Medical Imaging Systems
    • Optical Imaging
    • Magnetic Resonance Imaging (MRI)
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
    • Computed Tomography (CT)
    • Ultrasound Imaging (US)
    • Photoacoustic Imaging (PAI)
    • Hybrid Imaging Systems
    • Imaging Microscopes
    • Endoscopes
    • Others
  • Animal Patient Monitoring & Life Support Systems
    • Multiparameter Monitoring Systems
    • Physiology Monitoring Devices
    • Anesthesia Machines & Vaporizers
    • Ventilators & Respiratory Support
    • Infusion, Syringe & Precision Pumps
    • Temperature Management Systems
    • Data Collection & Acquisition Systems
    • Others
  • Animal Housing & Husbandry Systems
    • Housing Cages
    • Watering & Feeding Systems
    • Rack & Cage Ventilation Systems
    • Others
  • Pre-clinical Surgical Systems & Accessories
    • Stereotaxic Surgery Systems
    • Surgical Instruments & Toolkits
    • Surgical Lasers
    • Surgical Microscopes & Magnification Tools
    • Surgical Tables & Stabilization Systems
    • Optical & Illumination Systems
    • Warming Plates & Heating Pads
    • Others
  • Microinjection, Dosing & Sampling Systems
    • Microinjection Pumps & Osmotic Pumps
    • Sampling Devices
    • Valves, Tubing & Precision Delivery Accessories
    • Vascular Access Devices
    • Injection Systems (Manual, Automated)
    • Others
  • Pre-clinical Interventional Devices
    • Catheters & Microcatheters
    • Guidewires
    • Minimally Invasive Surgical Tools
    • Balloon & Vascular Tools
    • Others
  • Euthanasia Systems
  • Consumables
  • Others
  • Animal Model Outlook (Revenue, USD Million, 2021 - 2033)
  • Rodents
  • Rabbits
  • Non-Human Primates
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Neurology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Metabolic Disorders
  • Others
  • Customer Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • Preclinical CROs & Contract Laboratories
  • Academic & Research Institutions
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • U.S.
  • Canada

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Model
    • 1.2.3. Application
    • 1.2.4. Customer
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Pre-clinical Scientific Research Medical Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Pre-Clinical R&D Spending by Medical Device Companies
      • 3.2.1.2. Stringent Regulatory and Safety Requirements
      • 3.2.1.3. Technological Advancements and Shift Toward Translational Research Models
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance Issues While Outsourcing
      • 3.2.2.2. Data Insecurity
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges
  • 3.3. Value Chain Analysis
    • 3.3.1. Supply Trends
    • 3.3.2. Demand Trends
  • 3.4. R&D Investment & Funding Landscape
  • 3.5. Business Model Analysis
    • 3.5.1. OEM Go-to-Market Models
    • 3.5.2. Direct Sales vs. Distributor / Dealer Models
    • 3.5.3. Service, Maintenance, and After-Sales Business Models
    • 3.5.4. Bundled Offerings and Long-Term Supply Agreements
  • 3.6. Pricing Analysis
  • 3.7. Technology Landscape
  • 3.8. Customers and Buying Behavior Analysis
  • 3.9. Role of Equipment in Preclinical Study Workflows
  • 3.10. OEM Opportunity Analysis
    • 3.10.1. Product Fit-Gap Analysis
    • 3.10.2. Overview of Mindray Animal Product Relevance
    • 3.10.3. Strategic Entry Points in Patient Monitoring & Anesthesia Equipment
    • 3.10.4. Competitive Positioning Against Premium OEMs
    • 3.10.5. Price-Tier Differentiation Opportunities
    • 3.10.6. Potential Penetration into CROs, Academia, and Vivarium Environments
  • 3.11. Industry Analysis Tools
    • 3.11.1. Porter's Five Force Analysis
    • 3.11.2. PESTEL by SWOT Analysis

Chapter 4. North America Pre-clinical Scientific Research Medical Device Market: Product Estimates & Trend Analysis

  • 4.1. North America Pre-clinical Scientific Research Medical Device Market, By Product: Segment Dashboard
  • 4.2. North America Pre-clinical Scientific Research Medical Device Market, By Product: Movement Analysis
  • 4.3. North America Pre-clinical Scientific Research Medical Device Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
  • 4.4. Pre-clinical IVD Systems & Reagents
    • 4.4.1. Pre-clinical IVD Systems & Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Hematology Analyzers
      • 4.4.2.1. Hematology Analyzers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Clinical Chemistry Analyzers
      • 4.4.3.1. Clinical Chemistry Analyzers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Immunoassay Platforms
      • 4.4.4.1. Immunoassay Platforms Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Molecular Diagnostics
      • 4.4.5.1. Molecular Diagnostics Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Pre-clinical Medical Imaging Systems
    • 4.5.1. Pre-clinical Medical Imaging Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Optical Imaging
      • 4.5.2.1. Optical Imaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Magnetic Resonance Imaging (MRI)
      • 4.5.3.1. Magnetic Resonance Imaging (MRI) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Positron Emission Tomography (PET)
      • 4.5.4.1. Positron Emission Tomography (PET) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Single Photon Emission Computed Tomography(SPECT)
      • 4.5.5.1. Single Photon Emission Computed Tomography (SPECT) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Computed Tomography (CT)
      • 4.5.6.1. Computed Tomography (CT) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Ultrasound Imaging (US)
      • 4.5.7.1. Ultrasound Imaging (US) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.8. Photoacoustic Imaging (PAI)
      • 4.5.8.1. Photoacoustic Imaging (PAI) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.9. Hybrid Imaging Systems
      • 4.5.9.1. Hybrid Imaging Systems Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.10. Imaging Microscopes
      • 4.5.10.1. Imaging Microscopes Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11. Endoscopes
      • 4.5.11.1. Endoscopes Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.12. Others
      • 4.5.12.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Animal Patient Monitoring & Life Support Systems
    • 4.6.1. Animal Patient Monitoring & Life Support Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Multiparameter Monitoring Systems
      • 4.6.2.1. Multiparameter Monitoring Systems Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Physiology Monitoring Devices
      • 4.6.3.1. Physiology Monitoring Devices Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Anesthesia Machines & Vaporizers
      • 4.6.4.1. Anesthesia Machines & Vaporizers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Ventilators & Respiratory Support
      • 4.6.5.1. Ventilators & Respiratory Support Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.6. Infusion, Syringe & Precision Pumps
      • 4.6.6.1. Infusion, Syringe & Precision Pumps Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.7. Temperature Management Systems
      • 4.6.7.1. Temperature Management Systems Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.8. Data Collection & Acquisition Systems
      • 4.6.8.1. Data Collection & Acquisition Systems Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.9. Others
      • 4.6.9.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Animal Housing & Husbandry Systems
    • 4.7.1. Animal Housing & Husbandry Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Housing Cages
      • 4.7.2.1. Housing Cages Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Watering & Feeding Systems
      • 4.7.3.1. Watering & Feeding Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Rack & Cage Ventilation Systems
      • 4.7.4.1. Rack & Cage Ventilation Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Others
      • 4.7.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Pre-clinical Surgical Systems & Accessories
    • 4.8.1. Pre-clinical Surgical Systems & Accessories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.2. Stereotaxic Surgery Systems
      • 4.8.2.1. Stereotaxic Surgery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.3. Surgical Instruments & Toolkits
      • 4.8.3.1. Surgical Instruments & Toolkits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.4. Surgical Lasers
      • 4.8.4.1. Surgical Lasers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.5. Surgical Microscopes & Magnification Tools
      • 4.8.5.1. Surgical Microscopes & Magnification Tools Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.6. Surgical Tables & Stabilization Systems
      • 4.8.6.1. Surgical Tables & Stabilization Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.7. Optical & Illumination Systems
      • 4.8.7.1. Optical & Illumination Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.8. Warming Plates & Heating Pads
      • 4.8.8.1. Warming Plates & Heating Pads Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.9. Others
      • 4.8.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Microinjection, Dosing & Sampling Systems
    • 4.9.1. Microinjection, Dosing & Sampling Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.9.2. Microinjection Pumps & Osmotic Pumps
      • 4.9.2.1. Microinjection Pumps & Osmotic Pumps Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.9.3. Sampling Devices
      • 4.9.3.1. Sampling Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.9.4. Valves, Tubing & Precision Delivery Accessories
      • 4.9.4.1. Valves, Tubing & Precision Delivery Accessories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.9.5. Vascular Access Devices
      • 4.9.5.1. Vascular Access Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.9.6. Injection Systems
      • 4.9.6.1. Injection Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.9.7. Others
      • 4.9.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Pre-clinical Interventional Devices
    • 4.10.1. Pre-clinical Interventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.10.2. Catheters & Microcatheters
      • 4.10.2.1. Catheters & Microcatheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.10.3. Guidewires
      • 4.10.3.1. Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.10.4. Minimally Invasive Surgical Tools
      • 4.10.4.1. Minimally Invasive Surgical Tools Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.10.5. Balloon & Vascular Tools
      • 4.10.5.1. Balloon & Vascular Tools Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.10.6. Others
      • 4.10.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Euthanasia Systems
    • 4.11.1. Euthanasia Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Consumables
    • 4.12.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Others
    • 4.13.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America Pre-clinical Scientific Research Medical Device Market: Animal Model Estimates & Trend Analysis

  • 5.1. North America Pre-clinical Scientific Research Medical Device Market, By Animal Model: Segment Dashboard
  • 5.2. North America Pre-clinical Scientific Research Medical Device Market, By Animal Model: Movement Analysis
  • 5.3. North America Pre-clinical Scientific Research Medical Device Market Estimates & Forecasts, By Animal Model, 2021 - 2033 (USD Million)
  • 5.4. Rodents
    • 5.4.1. Rodents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Rabbits
    • 5.5.1. Rabbits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Non-Human Primates
    • 5.6.1. Non-Human Primates Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America Pre-clinical Scientific Research Medical Device Market: Application Estimates & Trend Analysis

  • 6.1. North America Pre-clinical Scientific Research Medical Device Market, By Application: Segment Dashboard
  • 6.2. North America Pre-clinical Scientific Research Medical Device Market, By Application: Movement Analysis
  • 6.3. North America Pre-clinical Scientific Research Medical Device Market Estimates & Forecasts, By Application, 2021 - 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Neurology
    • 6.5.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Cardiovascular Diseases
    • 6.6.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Infectious Diseases
    • 6.7.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Metabolic Disorders
    • 6.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America Pre-clinical Scientific Research Medical Device Market: Customer Estimates & Trend Analysis

  • 7.1. North America Pre-clinical Scientific Research Medical Device Market, By Customer: Segment Dashboard
  • 7.2. North America Pre-clinical Scientific Research Medical Device Market, By Customer: Movement Analysis
  • 7.3. North America Pre-clinical Scientific Research Medical Device Market Estimates & Forecasts, By Customer, 2021 - 2033 (USD Million)
  • 7.4. Pharmaceutical & Biopharmaceutical Companies
    • 7.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Preclinical CROs & Contract Laboratories
    • 7.5.1. Preclinical CROs & Contract Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic & Research Institutions
    • 7.6.1. Academic & Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America Pre-clinical Scientific Research Medical Device Market: Country Estimates & Trend Analysis

  • 8.1. Country Market Dashboard
  • 8.2. Country Market Share Analysis, 2025 & 2033
  • 8.3. U.S.
    • 8.3.1. Key Country Dynamics
    • 8.3.2. Competitive Scenario
    • 8.3.3. Regulatory Framework
    • 8.3.4. U.S. Market Estimates and Forecasts, 2021-2033 (USD Million)
  • 8.4. Canada
    • 8.4.1. Key Country Dynamics
    • 8.4.2. Competitive Scenario
    • 8.4.3. Regulatory Framework
    • 8.4.4. Canada Market Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Key Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Bruker Corporation
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Revvity, Inc. (PerkinElmer)
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Rigaku (MILabs B.V.)
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Thermo Fisher Scientific Inc.
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Agilent Technologies, Inc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Molecular Devices (Danaher)
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Carl Zeiss Microscopy
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Nikon Instruments
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Olympus / Evident Scientific
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. CytoViva, Inc.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. FUJIFILM VisualSonics
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. MBF Bioscience
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Mediso Ltd.
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. MR Solutions
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Siemens Healthineers
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제